I'm long - and hoping to recover my current 60% paper loss. But WHY these dramatic posts about "massive" covering. This stock goes up 4% all the time and give it up just as easily....so I doubt the shorts are covering and if they are it's just so they can short it again.
But the company has taken in CASH from selling the stock - so surely that increases the enterprise value to balance out the equity that was diluted...is how I think about it.
I think this is the first time I actually had stock in a company being bought out. Of course on this one - the buyout occurs with zero premium to the price at the time of announcement.
real smart comment since GLW was down about 1/3 of the major indices today. Since you hate everyone who likes this stock - why are you even here?
Wouldn't the Big Biotecs that have roared for 18 months come calling with buyout offers in a stock deal?
Somehow I found a way to own a #$%$ biotech in a roaring biotech market, 2 #$%$ utiliites, the worst big pharma (teva), and an fracking play that has lost 60% this year.
I'm hoping that this one will pay off one day.....but the predictions of pps in the many hundreds just seem absurd - especially given all of the other cancer drugs out there. If 102 is so special, why don't we hear more about it?
He was completely overrated the whole time. Made a good decision to borrow a ton of money to avoid a bailout - what else has he done for quality, reliability, ?
Have been a shareholder for about a year. With the recent pop in rates, I would have expected a pop in the share price. What concerns about NAT are holding this back? Or is it believed the rate spike is very temporary? Tax loss selling? Thoughts?
New to this stock. What is holding it back. Why down 1% on an up day. With so much cash, a cool new product, future revenues from patents --- what is the problem?
Can't keep pace with the market. When will the mgmt be held accountable? Keep hearing about their wonderful innovation....but where is it? where is the consistent growth?
After a few years of watching this pos fail to sustain any sort of rally - or even keep pace with the market averages despite it's "value" and future opportunities - it's enough to send anyone nuts.
Yesterday was all positive based on intel future product plans....after the close, the news hit about 2014 guidance being flat with 2013.